Evidence map›Paper›PMID 35347634›Full record

ArticleNeurochemical research2022

JNK1-Dependent Phosphorylation of GAP-43 Serine 142 is a Novel Molecular Marker for Axonal Growth.

Masayasu Okada, Yosuke Kawagoe, Toshiyuki Takasugi, Motohiro Nozumi, Yasuyuki Ito, Hayato Fukusumi, Yonehiro Kanemura, Yukihiko Fujii, Michihiro Igarashi

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Neurochemical research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Masayasu OkadaDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan.
Yosuke KawagoeDepartment of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, Japan.
Toshiyuki TakasugiDepartment of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, Japan.
Motohiro NozumiDepartment of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, Japan.
Yasuyuki ItoDepartment of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, Japan.
Hayato FukusumiDepartment of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Yonehiro KanemuraDepartment of Biomedical Research and Innovation, Institute for Clinical Research, National Hospital Organization Osaka National Hospital, Osaka, Japan.
Yukihiko FujiiDepartment of Neurosurgery, Brain Research Institute, Niigata University, Niigata, Japan.
Michihiro IgarashiDepartment of Neurochemistry and Molecular Cell Biology, School of Medicine and Graduate School of Medical/Dental Sciences, Niigata University, Niigata, Japan. tarokaja@med.niigata-u.ac.jp.ORCID http://orcid.org/0000-0003-1474-3385
Niigata University · JPOsaka National Hospital · JPNiigata University Medical and Dental Hospital · JP

Funding

Japan Agency for Medical Research and Development #19gm1210007s0101Japan Agency for Medical Research and Development #20gm1210007s0102Japan Agency for Medical Research and Development #21gm1210007s0103Japan Agency for Medical Research and Development #JP21bm0204001Japan Agency for Medical Research and Development #JP21bm0804024Japan Society for the Promotion of Science #17K10888Japan Society for the Promotion of Science #17K17739Japan Society for the Promotion of Science #18H04013Japan Society for the Promotion of Science #18K06459Japan Society for the Promotion of Science #20K15897Japan Society for the Promotion of Science #20K17955Japan Society for the Promotion of Science #21H03042Japan Society for the Promotion of Science #21K19305Ministry of Education, Culture, Sports, Science and Technology #18H04670
6 · The paper itself

Abstract

Mammalian axon growth has mechanistic similarities with axon regeneration. The growth cone is an important structure that is involved in both processes, and GAP-43 (growth associated protein-43 kDa) is believed to be the classical molecular marker. Previously, we used growth cone phosphoproteomics to demonstrate that S96 and T172 of GAP-43 in rodents are highly phosphorylated sites that are phosphorylated by c-jun N-terminal protein kinase (JNK). We also revealed that phosphorylated (p)S96 and pT172 antibodies recognize growing axons in the developing brain and regenerating axons in adult peripheral nerves. In rodents, S142 is another putative JNK-dependent phosphorylation site that is modified at a lower frequency than S96 and T172. Here, we characterized this site using a pS142-specific antibody. We confirmed that pS142 was detected by co-expressing mouse GAP-43 and JNK1. pS142 antibody labeled growth cones and growing axons in developing mouse neurons. pS142 was sustained until at least nine weeks after birth in mouse brains. The pS142 antibody could detect regenerating axons following sciatic nerve injury in adult mice. Comparison of amino acid sequences indicated that rodent S142 corresponds to human S151, which is predicted to be a substrate of the MAPK family, which includes JNK. Thus, we confirmed that the pS142 antibody recognized human phospho-GAP-43 using activated JNK1, and also that its immunostaining pattern in neurons differentiated from human induced pluripotent cells was similar to those observed in mice. These results indicate that the S142 residue is phosphorylated by JNK1 and that the pS142 antibody is a new candidate molecular marker for axonal growth in both rodents and human.

Indexed as

AxonsNerve RegenerationAnimalsGAP-43 ProteinHumansJNK Mitogen-Activated Protein KinasesMammalsMiceMitogen-Activated Protein Kinase 8PhosphorylationSerineGAP-43 ProteinJNK Mitogen-Activated Protein KinasesMitogen-Activated Protein Kinase 8SerineAxon growthAxon regenerationBrain developmentGAP-43HumanPhosphoproteomicsPhosphorylation

Identifiers

PMID35347634
OpenAlexW4220792638

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.